Skip to content

Lipofilling for Healing of Chronic Wounds

Clinical Trial to Improve Wound Healing of Chronic Lower Leg Ulcers by Autologous Transplantation of Fat Tissue

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05509673
Enrollment
34
Registered
2022-08-22
Start date
2011-06-29
Completion date
2017-03-06
Last updated
2022-08-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wound Healing Disorder

Brief summary

Chronic wounds remain a therapeutic and financial challenge for physicians and the health care systems. Innovative, cheap and effective treatment methods would be of immense value. The sublesional fat grafting could be such treatment, although the effectiveness and safety have not been assessed in large randomized clinical trials. The aim of this trial was to analyse the effect of adipose tissue on the healing of chronic lower leg wounds. For this purpose, the wounds were surgically cleaned (wound debridement) and then fat was suctioned out from the stomach or thighs and then injected into the edges of the wound and under the wounds. The wounds are covered with a foam dressing that is changed every 3-4 days. There are controls on days 3, 7, 14 and 21 after the intervention and a follow-up examination 2 months after the intervention. The primary objective is the reduction of the wound area 14 days and 2 month after intervention. Secondary objectives are pain level of the wound, bacterial colonialisation of the wound and analysis of the grafted fat tissue (ammount of mesenchymal stem cells)

Interventions

OTHERLipofilling (sublesional fat grafting)

Sponsors

Cologne-Merheim Medical Center (CMMC)
CollaboratorUNKNOWN
University of Witten/Herdecke
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Digital analysis of wound area is masked

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with leg ulcers of any origin (venous, arterial, mixed arterial-venous, diabetogenic, compressive) * Age of ulcer \> 6 weeks * Ulcer size \>= 1 cm (minimum diameter) * Ulcer / wound with complete destruction of the epidermis (including basement membrane) * Patient age \> 18 years * Patient Consent

Exclusion criteria

* Pregnancy * Exposed tendons, ligaments, or bone if maximum diameter \> 2 mm * Ulcer size \> 10 cm * Immediately preceding vacuum bandage therapy (\< 2 weeks) * Possibilities for correcting the cause of the ulcer

Design outcomes

Primary

MeasureTime frameDescription
Reduction of wound area14 days and 2 monthThe reduction of the wound area from intervention to 14 days and 2 month post-intervention

Secondary

MeasureTime frameDescription
Pain wound2 monthSubjective pain level of the patient in the area of the wound, measured by the visual analogue scale pre and post intervention
Bacterial contamination wound3 weeksWound swabs were taken pre intervention and on days 7, 14 and 21 after intervention

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026